Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
follistim + ganirelix
- Development stage
- Phase 4
- Lead developer
- Organon
- Modality
- Peptide-Drug Conjugates → Peptide Conjugates → Peptides, Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
Follistim + Ganirelix is a combination regimen used in assisted reproductive technology (ART), particularly in in vitro fertilization (IVF) protocols. Follistim contains follitropin beta, a recombinant form of follicle-stimulating hormone (FSH), which stimulates the growth and maturation of ovarian follicles to increase the number of eggs available for retrieval. Ganirelix is a gonadotropin-releasing hormone (GnRH) antagonist that prevents premature luteinizing hormone (LH) surges and ovulation during controlled ovarian hyperstimulation. The combination allows for optimal follicular development while precisely controlling ovulation timing to maximize egg retrieval success[2][6][8][9].
- Other names
- follitropin beta + ganirelixFollistim AQ + Ganirelix
02
Targets
FSHR (Follicle-stimulating hormone receptor)GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on follistim + ganirelix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on follistim + ganirelix.